Malwarebytes Valuation Analysis: Latest Market Insights & Trends

Hill Chart Shape

Malwarebytes Valuation and Overview

Malwarebytes
Sectors
Security, SaaS, Privacy
Headquarters
Santa Clara, CA, USA
CEO
Malwarebytes shares, as of April 21, 2025, are valued at a price per share implying an approximate +42.83% relative to the most recent significant secondary market activity in June 2024, according to PM Insights' market data. PM Insights uses a market-driven derived price methodology to determine Malwarebytes's valuation when recent secondary market transactions are limited or unavailable, as is currently the case for Malwarebytes.
Register today to view the full report, with more in-depth details and analytics
Latest funding round
XXXXX
XX-XX-XXXX
AV Implied Valuation
XXXXX
XX-XX-XXXX
Change since Last Round
XXXXX
XX-XX-XXXX
Secondary Activity
XXXXX

Business Partnerships

Targeted Impact

Who Will Benefit?

What Comes Next?

Malwarebytes Growth Timeline

No items found.

Malwarebytes and Competition

For additional insights and information on Malwarebytes, contact us today to access the full ApeVue report.
Request the full report

Malwarebytes Market Inteligence Snapshot

Malwarebytes Annual Revenue & Year-Over-Year Growth Rate

Malwarebytes Secondary Market ROI (Return on Investment)

Malwarebytes shares, as of April 21, 2025, are valued at a price per share implying an approximate +42.83% relative to the most recent significant secondary market activity in June 2024, according to PM Insights' market data. PM Insights uses a market-driven derived price methodology to determine Malwarebytes's valuation when recent secondary market transactions are limited or unavailable, as is currently the case for Malwarebytes.

Malwarebytes Bid-Ask Volume Ratios (Private Secondary Market)

Malwarebytes Mutual Fund Valuations (NAV)

Malwarebytes's mutual fund disclosures indicate a three-month moving average fund price per share of $8.34 as of September 29, 2024, according to PM Insights' market data.

Malwarebytes Funding Rounds & Cap Table Details

Register today to view the full report, with more in-depth details and analytics:
Access the full report

Malwarebytes VC / Strategic Investors

Malwarebytes Research

No items found.

Malwarebytes News

No items found.
Register today to view the full Malwarebytes report, with more in-depth details and analytics:
Access the full Malwarebytes report

Ready to see it in action?

Schedule a demo with one of our experts